Oruka Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Oruka Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis (NCT07474792) | Oruka Therapeutics, Inc. | 2026-03-19 |
| Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis (NCT07290569) | Oruka Therapeutics, Inc. | 2025-12-03 |
| ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis (NCT07090330) | Oruka Therapeutics, Inc. | 2025-07-18 |
| ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose (NCT06944379) | Oruka Therapeutics, Inc. | 2025-05-19 |
| ORKA-001 in Healthy Volunteers (NCT06698939) | Oruka Therapeutics, Inc. | 2024-12-19 |
Track Oruka Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.